AT1 receptor antagonist telmisartan administered peripherally inhibits central responses to angiotensin II in conscious rats

Journal of Pharmacology and Experimental Therapeutics

Volumn 298, Issue 1, 2001, Pages 62-70

  Gohlke, P ^a,b   Weiss, S ^a   Jansen, A ^a   Wienen, W ^c   Stangier, J ^a,c   Rascher, W ^d   Culman, J ^a,b   Unger, T ^a,b  

^a UNIVERSITY OF KIEL   (Germany)

^b German Institute for High Blood Pressure Research   (Germany)

^c BOEHRINGER INGELHEIM PHARMA GMBH AND CO KG   (Germany)

^d UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN; ANGIOTENSIN 1 RECEPTOR ANTAGONIST; TELMISARTAN; VASOPRESSIN; ANGIOTENSIN 1 RECEPTOR; ANGIOTENSIN 2 RECEPTOR; ANGIOTENSIN CONVERTING ENZYME INHIBITORS; ANGIOTENSIN RECEPTOR; ARGIPRESSIN; BENZIMIDAZOLE DERIVATIVE; BENZOIC ACID DERIVATIVE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; VASOCONSTRICTOR AGENT;

ANIMAL EXPERIMENT; ARTICLE; BLOOD BRAIN BARRIER; DRINKING; DRUG ACTIVITY; DRUG CEREBROSPINAL FLUID LEVEL; MALE; MEAN ARTERIAL PRESSURE; NONHUMAN; PRESSOR RESPONSE; PRIORITY JOURNAL; RAT; VASOPRESSIN RELEASE; ANIMAL; BLOOD; BLOOD PRESSURE; DRUG EFFECT; METABOLISM; PHYSIOLOGY; RAT STRAIN;

ANGIOTENSIN II; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ANIMAL; ARGIPRESSIN; BENZIMIDAZOLES; BENZOATES; BLOOD PRESSURE; BLOOD-BRAIN BARRIER; DRINKING; MALE; RATS; RATS, WISTAR; RECEPTORS, ANGIOTENSIN; VASOCONSTRICTOR AGENTS;

EID: 0034743612     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (39)

1. Cognitive enhancing actions of Dup 753 detected in a mouse habituation paradigm
2. Losartan potassium, a nonpeptide antagonist of angiotensin II, chronically administered p.o. does not readily cross the blood-brain barrier
3. Effects of systemic treatment with irbesartan and losartan on central responses to angiotensin II in conscious, normotensive rats
4. 1 receptors improves neurological outcome and reduces expression of AP-1 transcription factors after focal brain ischemia in rats
5. International Union of Pharmacology. XXIII The angiotensin II receptors
6. The RAS (renin-angiotensin system): Physiology and pathophysiology
7. 1 receptors on the recovery from focal cerebral ischemia in normotensive rats
8. Cardiac and vascular effects of long-term losartan treatment in stroke prone spontaneously hypertensive rats
9. Angiotensin receptors and their therapeutic implications
10. 1 receptor mRNA and angiotensinogen mRNA in the brain of spontaneously hypertensive rats reduces hypertension of neurogenic origin
11. Long-term inhibition of renin-angiotensin system sustains memory function in aged Dahl rats
12. The neuroendocrinology of thirst: Afferent signaling and mechanisms of central integration
13. 2 receptors in NG108-15 cells
14. Functional evidence that the angiotensin antagonist losartan crosses the blood-brain barrier in the rat
15. 2) receptor promotes axonal regeneration in the optic nerve of adult rats
16. Repeated measurements and multiple comparisons in cardiovascular research
17. 2 receptor inhibits proliferation and promotes differentiation in PC12 W cells
18. 1-receptor blockers in isolated vessels of different origin
19. Chronic peripheral administration of the angiotensin II AT1 receptor antagonist candesartan blocks brain AT1 receptors
20. Angiotensin II in central nervous system physiology
21. Evaluation of the ability of irbesartan to cross the blood-brain barrier following acute intragastric treatment
22. 1 receptor antagonists to cross the blood-brain barrier in rats
23. 1 receptors in the supraoptic nucleus
24. Sites and functions of the blood-brain barrier
25. Vasopressin in the plasma of stroke-prone spontaneously hypertensive rats
26. Cardiovascular effects of microinjections of angiotensin II into the nucleus tractus solitarii
27. Barrier mechanisms in the brain I. Adult brain
28. Brain and pituitary angiotensin
29. Access of peripherally administered DuP 753 to rat brain angiotensin receptors
30. Brain angiotensin: Pathways and pharmacology
31. Angiotensin receptors
32. Involvement of adrenergic and angiotensinergic receptors in the paraventricular nucleus in the angiotensin II-induced vasopressin release
33. Angiotensin II receptor antagonist CV-11974 and cerebral blood flow autoregulation
34. Effects of AT1 receptor blockade on blood pressure and the renin-angiotensin system in spontaneously hypertensive rats of the stroke prone strain
35. Pharmacological characterization of the novel nonpeptide angiotensins II receptor antagonist, BIBR 277
36. A review on telmisartan: A novel, long-acting angiotensin II-receptor antagonist
37. Comparative antihypertensive and renoprotective effects of telmisartan and lisinopril after long-term treatment in hypertensive diabetic rats
38. Nonpeptide angiotensin II receptor antagonists. VIII. Characterization of functional antagonism displayed by DuP 753, an orally active antihypertensive agent
39. 1 angiotensin II receptors in rat brain, kidney and adrenals demonstrated by in vitro autoradiography